Abstract Details

Title Oral Fingolimod (FTY720) in Relapsing-Remitting Multiple Sclerosis: Baseline Patient Demographics and Disease Characteristics from a 2-Year Phase III Trial (FREEDOMS II)

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 038

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
	No disclosure on file
Bingbing Li	Bingbing Li has received personal compensation for serving as an employee of Novartis.
Rebecca Gottschalk (Novartis Pharmaceuticals)	No disclosure on file
Manoj Malhotra, MD	Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��